This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents. Specifically, the company failed to properly reimburse pharmacies, favored its own specialty pharmacy operations by paying higher dispensing fees than to other pharmacies, and did not properly handle appeals filed by pharmacies, accor
Following the overturn of Leqselvis injunction in the US market on 10 April 2025: Vinie Varkey, Pharma Analyst at GlobalData offers her view, Sun Pharmas Leqselvi has a strong chance to see quick patient uptake in the US. The JAK 1/2 inhibitor was approved by the FDA in July 2024 for treatment of adults with severe alopecia areata (AA); however, a patent ruling in November 2024 resulted in an injunction blocking the commercial release of the drug in the US.
By Sarah Wicks & Dara Katcher Levy FDAs Office of Prescription Drug Promotion (OPDP) issued its second Untitled Letter of 2025 to Taiho Oncology (Taiho) for a healthcare provider branded website for its drug LYTGOBI (futibatinib). This letter, dated March 21, 2025, cites Taihos false or misleading representations about the benefits of the drug, which is considered misbranding under the Federal Food, Drug, and Cosmetic Act.
In this episode, Ill discuss 10 tips for providing effective feedback to PGY-1 residents. Episode 1017: Tips for providing effective feedback to PGY-1 residents Subscribe on iTunes , Android , or Stitcher When providing feedback, choose a location where both parties will be comfortable openly speaking. This may be done on the unit as long as others are not actively listening, but be especially sensitive to giving feedback to residents in front of students they are co-precepting.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
JR is an 88-year-old female who reports increasing episodes of dizziness upon standing over the past month. She describes it as a lightheaded sensation that lasts about 1015 seconds after getting up from bed or a chair. From a medical standpoint, we would likely call this orthostatic hypotension. She denies chest pain, palpitations, or visual […] The post Orthostatic Hypotension Case Study appeared first on Med Ed 101.
3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision control over drug release profiles, and near-endless possibilities in the geometric shaping of dosage forms. In this article, learn how 3D screen printing offers unmatched flexibility to tailor formulations for specific therapeutic needs and redefines whats possible in drug development and manufacturing.
3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision control over drug release profiles, and near-endless possibilities in the geometric shaping of dosage forms. In this article, learn how 3D screen printing offers unmatched flexibility to tailor formulations for specific therapeutic needs and redefines whats possible in drug development and manufacturing.
Can pharma brands remain relevant in a digital-first healthcare economy? As the industry pivots toward patient empowerment, AI-enabled solutions, and content-driven search, the real challenge isnt visibilityits authority. Much like the shift from blockbuster drugs to targeted therapies, digital transformation demands new approaches. In this article, well unpack the most effective SEO marketing strategies that align with pharma brands and the 2025 shifting strategyhelping you drive organic traffi
WEST PALM BEACH, Fla. — Donald Trump’s doctor says the oldest man to be elected president is “fully fit” to serve as commander in chief as the White House released the results of Trump’s physical exam from Friday. Trump is 78, and his physician, Navy Capt. Sean Barbabella, cited what he said is Trump’s “active lifestyle” and said it “continues to contribute significantly” to the Republican president’s well-being.
182
182
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content